Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. - Wikidata - awgldk - TriplyDB

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.

http://www.wikidata.org/entity/Q34328229

about

Coronary heart disease and hormone replacement therapy after the menopause Hormone therapy for preventing cardiovascular disease in post-menopausal women Hormone therapy for preventing cardiovascular disease in post-menopausal women Long term hormone therapy for perimenopausal and postmenopausal women Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.Gender differences in non-ischemic myocardial remodeling: are they due to estrogen modulation of cardiac mast cells and/or membrane type 1 matrix metalloproteinase Altered arterial stiffness in male-to-female transsexuals undergoing hormonal treatment Long-term hormone therapy for perimenopausal and postmenopausal women.Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis Association between hormone replacement therapy and subsequent stroke: a meta-analysis.The Women's international study of long-duration oestrogen after menopause (WISDOM): a randomised controlled trial.In Perspective: Estrogen Therapy Proves to Safely and Effectively Reduce Total Mortality and Coronary Heart Disease in Recently Postmenopausal Women Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended event A "window of opportunity:" the reduction of coronary heart disease and total mortality with menopausal therapies is age- and time-dependent.Main morbidities recorded in the women's international study of long duration oestrogen after menopause (WISDOM): a randomised controlled trial of hormone replacement therapy in postmenopausal women Brief report: Coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis.The continuing evolution of women's health.Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes.Aging and Loss of Circulating 17β-Estradiol Alters the Alternative Splicing of ERβ in the Female Rat Brain.Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.Cardiovascular health and the menopause: the gynecologist as the patients' interface.Why is cardiovascular health important in menopausal women?Managing cardiovascular risk in menopausal women.Meta-analysis: effect of hormone-replacement therapy on components of the metabolic syndrome in postmenopausal women.Drospirenone and estradiol: a new option for the postmenopausal woman.Menopause and cardiovascular disease: the evidence.The timing hypothesis for coronary heart disease prevention with hormone therapy: past, present and future in perspective Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis.Health related quality of life after combined hormone replacement therapy: randomised controlled trial The timing hypothesis and hormone replacement therapy: a paradigm shift in the primary prevention of coronary heart disease in women. Part 1: comparison of therapeutic efficacy.Advances in hormone replacement therapy: weight benefits of drospirenone, a 17alpha-spirolactone-derived progestogen.Vascular Effects of Early versus Late Postmenopausal Treatment with Estradiol New evidence rekindles the hormone therapy debate.Vascular actions of estrogens: functional implications.Postmenopausal hormone therapy and cardiovascular disease in perspective.Association of Age at Menopause With Incident Heart Failure: A Prospective Cohort Study and Meta-Analysis.A review of the cardiovascular and breast actions of drospirenone in preclinical studies.Soy consumption during menopause.Hormone replacement therapy reduces lipid oxidation directly at the arterial wall: A possible link to estrogens' cardioprotective effect through atherosclerosis prevention.Evidence-based assessment of the impact of the WHI on women's health.

P2860

Q22248005-E970C9FB-5F8C-4AE3-BFE6-113CE8C2FB86 Q24187326-89E9D7DA-98E2-4019-83A6-298796FC7394 Q24197712-210EBF0B-C983-42B5-AE67-F170DD4179ED Q24201974-87ED1248-A33A-45B9-9FA8-0DF1AC5F8824 Q24658109-BC95FD44-CDE6-4DAE-8BBF-B0F5A3801DB1 Q26998447-3D36A304-DAA7-4FB9-9051-E8FCDBB2EA70 Q28264005-AF05D21B-4FDA-4852-99D1-6850EA70571E Q30238978-11C6F317-98EB-47ED-B85F-FBA873451071 Q30868399-9EA67307-C5E4-40B2-8660-6C7A36A0A63D Q33210702-C82FDB95-EBA2-4E08-ACC0-30C57303E5C6 Q33275630-CD9A3AD8-E91F-41AB-B96B-D09789C9F39B Q33862138-5CBBC017-E827-4319-B54A-175945B1A4E1 Q34254787-CCD11060-FF9E-4848-B656-E9BACED5BD79 Q34612394-217791D6-2EDE-4740-90C2-B19BE44FCD4B Q34649417-C2784C7A-C59A-4AE3-AA55-87E3FEA678ED Q34704488-53410DB3-8997-4A52-914A-94C469700C6E Q34733230-A4762FE0-7929-48A6-9472-3D107879B68E Q35243693-6D0BE6AC-2409-4592-B805-5CC2E2BE1925 Q36164324-B1E27CDD-D757-4959-AA4E-527D29952950 Q36219667-9D35793D-C3AA-4AB4-9AE6-1A9B5912C933 Q36561352-5FD61C72-FB19-4FB3-809E-ACF9D51B6D32 Q36561356-73FB0AAD-05C7-46B4-8179-89257D5BD59F Q36561361-BABD500C-161C-4FAE-84D5-079D4846ED5D Q36570589-41F7CB5C-E7F3-4A97-A14D-803A05A3D197 Q36761429-4C4BDBF5-3D07-4453-97FA-8C0E022BEC43 Q36761433-72F3FD0D-BF2A-4183-9580-03B02F422620 Q36781520-0C9756B9-CF69-41CE-8D70-6EAEBBDD1F2E Q36836702-4373FB0D-F4BB-40E6-9D9E-83BAEDDB61F2 Q36843105-B0A79A55-D81B-4109-A23E-6DFF245EEFCA Q36863876-822EC9A8-27B5-45EA-9E97-AAEA1E0476F7 Q37030687-76FE79B7-66D3-45E0-AC8E-90AEBEF94AF3 Q37038435-0282146B-2B41-4FA6-AF81-F084D6616C8A Q37056135-9EDBD220-53B0-418D-9C34-080E6A62B05B Q37088243-EA8CB721-74F6-4BCF-B390-ADBDF1E30E38 Q37234323-AE98743B-8806-4234-83F4-C481CF92F912 Q37240444-B3E5A304-76B1-4672-BC42-B4271E0CCBFD Q37638712-930100E9-8A77-4A64-BFBB-F17310BDB0B9 Q37709873-EFD50010-F79F-4C41-8C5F-3EA724035977 Q37721919-39500706-DF89-46FC-9997-432BF1F1AFDF Q38011787-2D0AD49B-9028-4614-BE74-674F26C9567F

P2860

Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis.

http://www.wikidata.org/entity/Q34328229

description

2004 nî lūn-bûn

@nan

2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Mortality associated with horm ...... older women: a meta-analysis.

@ast

Mortality associated with horm ...... older women: a meta-analysis.

@en

Mortality associated with horm ...... older women: a meta-analysis.

@nl

type

label

Mortality associated with horm ...... older women: a meta-analysis.

@ast

Mortality associated with horm ...... older women: a meta-analysis.

@en

Mortality associated with horm ...... older women: a meta-analysis.

@nl

prefLabel

Mortality associated with horm ...... older women: a meta-analysis.

@ast

Mortality associated with horm ...... older women: a meta-analysis.

@en

Mortality associated with horm ...... older women: a meta-analysis.

@nl

P1433

Q34328229-2F31BC55-71DD-4100-919B-EB5F0DCBD4E4

P1476

Q34328229-58A2FF6C-E496-4FD4-A577-F4F824BCD255

P2093

Q34328229-2581D193-6BC1-4B32-9B6F-33A2F8BA0956

Q34328229-A5E0DC4A-F6FC-4C65-975C-91A14B9447D0

Q34328229-B52B08B1-9E49-4691-A110-881F993636F4

Q34328229-E9C53CDF-46B7-47F8-B289-BC395B87CFCA

Q34328229-F437C128-C13B-4B0F-913B-27D95CB1D925

P2860

Q34328229-05C3EC64-3648-4F5D-A7A5-369249F421A8

Q34328229-08544FE3-04CA-45EC-9C54-C1E5ECF6A90B

Q34328229-089FC6C0-7CA7-4165-A52F-8001C4C4C334

Q34328229-0BF96A1F-E60F-4EC3-BA82-2A0A6EA61F75

Q34328229-127D4041-2E17-4AAF-8E82-55868DCF2BF0

Q34328229-15007EDD-36E0-4A04-86AC-56C3EF6953FB

Q34328229-16206655-D00E-4014-B987-50A64DDF2FB8

Q34328229-1A6A6096-D683-42EA-BF4B-19F388865F11

Q34328229-1C84A05A-0C01-41B7-888E-0F88EEA75C0A

Q34328229-1D622C41-B47D-412B-B50B-6797A41083B5

P2888

Q34328229-E43C4CDE-B5DD-42B9-A3FA-FF109C03A014

P304

Q34328229-B43655B3-DF75-4C3B-95F6-8344B897B5AC

P31

Q34328229-CD95EA16-F66A-4239-9BD1-A5A697F6798E

Q34328229-e2f088ff-ad54-4d84-b255-5da053c69b5e

P356

Q34328229-35A6E80C-D865-4B0F-ABFC-BC1D0B1164E6

P433

Q34328229-3725AED7-33AA-4851-8732-D83299D4CD08

P478

Q34328229-0E26712A-814E-47F7-8272-B22D85EE4696

P577

Q34328229-512C7E6A-8542-4CEB-A09F-3627DF1271C8

P5875

Q34328229-675B699F-80AD-4054-80EA-D3FF59E1D700

P6179

Q34328229-273C1A78-DDFE-4C77-9FDA-E0911F8D3846

P698

Q34328229-4C406697-3C6F-4632-936F-6DB2F6314FA6

P921

Q34328229-D1622571-F3C3-4BD2-8E27-64AAB566E0CC

P932

Q34328229-322E18B9-3DD1-45B5-8536-DCAEF82C576D

P356

J.1525-1497.2004.30281.X

P1433

Journal of General Internal Medicine

P1476

Mortality associated with horm ...... older women: a meta-analysis.

@en

P2093

Edwin E Salpeter

http://www.w3.org/2001/XMLSchema#string

Elizabeth Greyber

http://www.w3.org/2001/XMLSchema#string

Judith M E Walsh

http://www.w3.org/2001/XMLSchema#string

Shelley R Salpeter

http://www.w3.org/2001/XMLSchema#string

Thomas M Ormiston

http://www.w3.org/2001/XMLSchema#string

P2860

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Meta-analysis in clinical trials

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Estrogen replacement therapy II: a prospective study in the relationship to carcinoma and cardiovascular and metabolic problems

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.

Understanding the divergent data on postmenopausal hormone therapy.

Hormone replacement improves hemodynamic profile and left ventricular geometry in hypertensive and normotensive postmenopausal women.

Conjugated equine estrogen improves glycemic control and blood lipoproteins in postmenopausal women with type 2 diabetes.

P2888

j.1525-1497.2004.30281.x

P304

791-804

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1525-1497.2004.30281.X

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2004-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8497780

http://www.w3.org/2001/XMLSchema#string

P6179

1028030494

http://www.w3.org/2001/XMLSchema#string

P698

15209595

http://www.w3.org/2001/XMLSchema#string

P921

P932

1492478

http://www.w3.org/2001/XMLSchema#string